期刊文献+

胚胎干细胞向神经细胞的诱导分化及其在神经系统退行性疾病的应用

Differentiation of embryonic stem cells into neural lineage and its potential application on neurodegenerative disorders
原文传递
导出
摘要 胚胎干细胞具有向三个胚层细胞分化的潜能,被视为治疗多种疾病包括神经系统退行性疾病的一种新兴手段。在现阶段,通过不同的诱导途径可将小鼠和人胚胎干细胞诱导成为神经前体细胞和特定类型的神经元,但现有的方法诱导得到的神经细胞比例较低且不易分拣出来。进一步解决这些问题,将为神经系统退行性疾病的临床治疗带来新的希望。 Embryonic stem (ES) cells are pluripotent cells with the potential to give rise to cell types of all three primary germ layers. ES cells have been regarded as a new cell source for cell replacement therapies including neurodegenerative disorders. Recently, differentiation of neural progenitors or specific type of neurons from mouse and human ES cells has been reported using several kinds of protocols. Although ES cells derived neural cells promise a potential for cell replacement therapies of neurodegenerative disorders, further research is needed to improve the efficiency of neural differentiation and the sorting of specific cell type.
出处 《国际生物医学工程杂志》 CAS 2007年第5期287-291,共5页 International Journal of Biomedical Engineering
基金 国家“973”计划重点基础研究发展规划资助项目(001CB509903,001CB509904)
关键词 胚胎干细胞 诱导分化 神经系统退行性疾病 embryonic stem cells (ESCs) differentiation neurodegenerative disorders
  • 相关文献

参考文献1

二级参考文献83

  • 1[74]Heath PR and Shaw PJ. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002; 26:438-58.
  • 2[75]Simpson EP, Yen AA, Appel SH. Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.Curr Opin Rheumatol. 2003; 15(6):730-6.
  • 3[76]Munch C, Ebstein M, Seefried U, et al. Alternative splicing of the 5′-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis.J Neurochem 2002; 82:594-603.
  • 4[77]Schuff N, Rooney WD, Miller R, et al. Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis. Magn Reson Med 2001; 45: 513-6.
  • 5[78]Reddy PH, Williams M, Tagle DA. Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci 1999; 22:248-55.
  • 6[79]Caramins M, Halliday G, McCusker E, and Trent RJ. Genetically confirmed clinical Huntington's disease with no observable cell loss. J Neurol Neurosurg Psychiatry 2003; 74:968-70.
  • 7[80]Law HY, Ng IS, Yoon CS, et al. Trinucleotide repeat analysis of Huntington's disease gene in Singapore; Ann Acad Med Singapore. 2001; 30(2): 122-7.
  • 8[81]Langbehn D, Brinkman R, Falush D, et al. On behalf of an International Huntington's Disease Collaborative Group dagger. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65(4):267-77.
  • 9[82]Hsu YY, Du AT, Schuff N, and Weiner MW. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.J Geriatr Psychiatry Neurol 2001; 14:145-66.
  • 10[83]Reynolds NC Jr, Hellman RS, Tikofsky RS, et al. Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington' s disease. Nucl Med Commun 2002; 23:13-8.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部